Macroaxis: Personalized Investing
Simple Personalized Investing

ABT MDT SYK ISRG Market Drivers Railroads Manufacturing Alcohol 
Benchmark SP 500  1,651   4.84  Index Moved Down -0.29% ...


Processing
Collecting data for MAKO

MAKO quote and profile

 
 Companies |  Insiders  | Dashboard  
     
11.29
  
STOCK
0.00  No Change   0.00%  
Year To Date
10.042.98
Last 1 Month(s)
10.3312.2
May 24 2013 

Diversification Suggestion

Use MAKO to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Analyze MAKO Surgical rp Trend or Check current 30 days MAKO correlation with market (S&P 500)
1 Month Beta 0.11  
Highest Price:  
Lowest Price:  
12.2  
10.33  
May 10 2013 
May 01 2013 
As returns on market increase, MAKO returns are expected to increase less than the market. However during bear market, the loss on holding MAKO will be expected to be smaller as well.
MAKO Surgical Corp Small BetaMAKO Surgical rp Beta Legend
MAKO United States Nasdaq
MAKO Surgical Corp
Healthcare
Medical Appliances and Equipment
Benchmark S&P 500
http://www.makosurgical.com
Contact Number: 954. 927. 2044
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation421.17 M
Shares Outstanding46.6 M
Number of Shares Shorted11.89 M
Revenue102.72 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.21 % Macroaxis: 0.21 Moved Up  
 
 thisGreen MAKO MAKO agains markets  0.00 % No Change  
 United States SP 500   0.29 % Macroaxis: 0.29 Moved Down  
 
 United States NYSE   0.44 % Macroaxis: 0.44 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

MAKO Leadership

Maurice MD Chairman of The Board, CEO and Pres
Maurice Ferre Chairman of the Board and Presidentident, CEO
Richard Leparmentier Senior Vice President - Engineering, MBA
Fritz LaPorte CFO, Senior Vice President - Finance and Administration, Treasurer

MAKO Price and Market Media

The median price of MAKO for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 11.0 with a coefficient of variation of 4.79. The daily time series for the period is distributed with a sample standard deviation of 0.53, arithmetic mean of 11.0, and mean deviation of 0.42. The Stock received substential amount of media coverage during this period.
MAKO         SP 500
Price Growth (%)
 
1
MAKO Surgical Corp. Schedules First Quarter 2013 Earnings Re...04/26/2013Macroaxis: News
2
Forbes Earnings Preview MAKO Surgical Corp .05/07/2013Macroaxis: Forbes News
3
MAKO Surgical Corp. It OK You Can Exhale Now05/09/2013Macroaxis: News
4
MAKO Surgical Corp. Notches Another Legal Victory05/21/2013Macroaxis: News
5
How MAKO Surgical Corp. Could Quadruple05/23/2013Macroaxis: News

MAKO Summary

MAKO Surgical Corp [MAKO] is traded on NASDAQ in USA. It is located in Fort Lauderdale, FL and employs 436 people. The company currently falls under 'Small-Cap' category with current market capitalization of 498.16 M. MAKO Surgical Corp conducts business under Healthcare sector and is part of Medical Appliances and Equipment industry. This company has 46.6 M outstanding shares of which 11.89 M shares are now shorted by private and institutional investors with about 12.0 trading days to cover.
MAKO Surgical Corporation, a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. more
Past Market
Over 30
Days
7
Out Of
100
 
Chance of
More
Than
78 %
 
Follow MAKO with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add MAKO to your reader
 

MAKO Research Report

MAKO vs. Abbott

Correlation analysis and fundamentals comparison between MAKO Surgical rp and Abbott Laboratories

MAKO Executives

Rony MS Co-Founder and Chief Visionary Officer
Fritz CPA CFO, Principal Accounting Officer, Sr. VP of Fin. and Admin. and Treasurer

MAKO Directors

John Freund Independent Director, MBA
John Savarese Independent Director, MBA
Frederic Moll Independent Director
Christopher Dewey Independent Director, MBA
Richard Pettingill Independent Director

MAKO Management

Lawrence Gibbons Sr. VP of Regulatory Affairs and Quality Assurance

MAKO Fundamentals

EBITDA vs Current Asset
Price to Book vs Number of Shares Shorted
EBITDA vs Current Ratio
Shares Owned by Institutions vs Number of Shares Shorted

MAKO vs Competition

MAKO vs. Abbott Laboratories
MAKO vs. Medtronic Inc
MAKO vs. Stryker Corporation
MAKO vs. Intuitive Surgical Inc
MAKO vs. Zimmer Holdings Inc
MAKO vs. St Jude Medical Inc
MAKO vs. Boston Scientific Corporation
MAKO vs. Smith Nephew plc
MAKO vs. Edwards Lifesciences Corp
MAKO vs. Varian Medical Systems Inc

MAKO May 24 2013 Opportunity Range

Downside Deviation3.2
Information Ratio0.0696
Maximum Drawdown13.61
Value At Risk(4.43)
Potential Upside3.89

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium